Open in new tab

Table 1. In multivariate analysis, potential risk factors.

6 models (each adjusted for age, gender, baseline creatinine)OR(95 % CI)p-value
BVAS1.05(1.01-1.10)0.013
Cutaneous4.07(1.97-8.37)0.001
Diabetes during follow-up0.60(0.20-1.77)0.355
GI5.60(1.93-16.22)0.002
Mucous Membrane / Eyes2.73(1.35-5.50)0.005
Subsequent Cancer2.47(1.11-5.52)0.027
6 models (each adjusted for age, gender, baseline creatinine)OR(95 % CI)p-value
BVAS1.05(1.01-1.10)0.013
Cutaneous4.07(1.97-8.37)0.001
Diabetes during follow-up0.60(0.20-1.77)0.355
GI5.60(1.93-16.22)0.002
Mucous Membrane / Eyes2.73(1.35-5.50)0.005
Subsequent Cancer2.47(1.11-5.52)0.027
Open in new tab

Table 1. In multivariate analysis, potential risk factors.

6 models (each adjusted for age, gender, baseline creatinine)OR(95 % CI)p-value
BVAS1.05(1.01-1.10)0.013
Cutaneous4.07(1.97-8.37)0.001
Diabetes during follow-up0.60(0.20-1.77)0.355
GI5.60(1.93-16.22)0.002
Mucous Membrane / Eyes2.73(1.35-5.50)0.005
Subsequent Cancer2.47(1.11-5.52)0.027
6 models (each adjusted for age, gender, baseline creatinine)OR(95 % CI)p-value
BVAS1.05(1.01-1.10)0.013
Cutaneous4.07(1.97-8.37)0.001
Diabetes during follow-up0.60(0.20-1.77)0.355
GI5.60(1.93-16.22)0.002
Mucous Membrane / Eyes2.73(1.35-5.50)0.005
Subsequent Cancer2.47(1.11-5.52)0.027
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close